RecruitingMethamphetamine IntoxicationMethamphetamine DisordersMethamphetamine Abuse
A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine
Eligible age
18–55 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of the study is to evaluate the safety, efficacy, and pharmacokinetics of four single, increasing doses of CS-1103, given by intravenous (IV) infusion in otherwise healthy, non-treatment seeking participants with methamphetamine use disorder in the presence of a clinically relevant dose of methamphetamine HCl (30 mg IV).
Sponsor: Clear Scientific, Inc.
Where it's recruiting
California
Glendale
Source: ClinicalTrials.gov · NCT06721494 · last updated 2026-01-12